Approval · Notice of Compliance 4497 · 1998
MIRALUMA: Notice of Compliance 4497
Issued November 1, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4497
- Date
- November 1, 1998
- Company
- Dupont Pharma Inc.Mississauga, Ontario, Canada
- Product type
- Radiopharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Diagnostic radiopharmaceutical for breast imaging
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MIRALUMA | Not yet assigned | — |